Disposition of Oral Cannabidiol-Rich Cannabis Extracts in Children with Epilepsy

ConclusionsIn pediatric patients using oral cannabidiol-rich cannabis extract for epilepsy, the time to peak concentration of plasma cannabidiol and average acute elimination half-life were shorter than those reported for adults. Co-administration of zonisamide and levetiracetam had some impact on cannabidiol pharmacokinetic parameters. There was an observed degradation of plasma cannabidiol in long-term storage.Clinical registrationClinicalTrials.gov Identifer no. NCT02447198.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research